These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

233 related items for PubMed ID: 28589433

  • 1. Overexpression of dishevelled 2 is involved in tumor metastasis and is associated with poor prognosis in hepatocellular carcinoma.
    Zhang C, Li C, Chen X, Zhou Y, Yin B, Ni R, Zhang Y, Liu J.
    Clin Transl Oncol; 2017 Dec; 19(12):1507-1517. PubMed ID: 28589433
    [Abstract] [Full Text] [Related]

  • 2. The suppressor of cytokine signaling 2 (SOCS2) inhibits tumor metastasis in hepatocellular carcinoma.
    Cui M, Sun J, Hou J, Fang T, Wang X, Ge C, Zhao F, Chen T, Xie H, Cui Y, Yao M, Li J, Li H.
    Tumour Biol; 2016 Oct; 37(10):13521-13531. PubMed ID: 27465557
    [Abstract] [Full Text] [Related]

  • 3. Hint1 suppresses migration and invasion of hepatocellular carcinoma cells in vitro by modulating girdin activity.
    Wu XS, Bao TH, Ke Y, Sun DY, Shi ZT, Tang HR, Wang L.
    Tumour Biol; 2016 Nov; 37(11):14711-14719. PubMed ID: 27623945
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Ack1 overexpression promotes metastasis and indicates poor prognosis of hepatocellular carcinoma.
    Lei X, Li YF, Chen GD, Ou DP, Qiu XX, Zuo CH, Yang LY.
    Oncotarget; 2015 Dec 01; 6(38):40622-41. PubMed ID: 26536663
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. miR-149 represses metastasis of hepatocellular carcinoma by targeting actin-regulatory proteins PPM1F.
    Luo G, Chao YL, Tang B, Li BS, Xiao YF, Xie R, Wang SM, Wu YY, Dong H, Liu XD, Yang SM.
    Oncotarget; 2015 Nov 10; 6(35):37808-23. PubMed ID: 26498692
    [Abstract] [Full Text] [Related]

  • 8. Downregulation of paraoxonase 3 contributes to aggressive human hepatocellular carcinoma progression and associates with poor prognosis.
    Jin Y, Li Q, Qiu J, Zhao X, Zheng C, Lv S, Bai Y, Shan Y, Ye LC.
    Tumour Biol; 2016 Oct 10; 37(10):14193-14203. PubMed ID: 27553024
    [Abstract] [Full Text] [Related]

  • 9. Suppression of the nuclear transporter-KPNβ1 expression inhibits tumor proliferation in hepatocellular carcinoma.
    Yang L, Hu B, Zhang Y, Qiang S, Cai J, Huang W, Gong C, Zhang T, Zhang S, Xu P, Wu X, Liu J.
    Med Oncol; 2015 Apr 10; 32(4):128. PubMed ID: 25794490
    [Abstract] [Full Text] [Related]

  • 10. Overexpression of Dishevelled-2 contributes to proliferation and migration of human esophageal squamous cell carcinoma.
    Zhou G, Ye J, Sun L, Zhang Z, Feng J.
    J Mol Histol; 2016 Jun 10; 47(3):287-95. PubMed ID: 27083564
    [Abstract] [Full Text] [Related]

  • 11. Upregulated FoxM1 expression induced by hepatitis B virus X protein promotes tumor metastasis and indicates poor prognosis in hepatitis B virus-related hepatocellular carcinoma.
    Xia L, Huang W, Tian D, Zhu H, Zhang Y, Hu H, Fan D, Nie Y, Wu K.
    J Hepatol; 2012 Sep 10; 57(3):600-12. PubMed ID: 22613004
    [Abstract] [Full Text] [Related]

  • 12. Up-regulation of long non-coding RNA Sox2ot promotes hepatocellular carcinoma cell metastasis and correlates with poor prognosis.
    Shi XM, Teng F.
    Int J Clin Exp Pathol; 2015 Sep 10; 8(4):4008-14. PubMed ID: 26097588
    [Abstract] [Full Text] [Related]

  • 13. High expression of TRIM44 is associated with enhanced cell proliferation, migration, invasion, and resistance to doxorubicin in hepatocellular carcinoma.
    Zhu X, Wu Y, Miao X, Li C, Yin H, Yang S, Lu X, Liu Y, Chen Y, Shen R, Chen X, He S.
    Tumour Biol; 2016 Nov 10; 37(11):14615-14628. PubMed ID: 27619678
    [Abstract] [Full Text] [Related]

  • 14. Decreased Expression of EHD2 Promotes Tumor Metastasis and Indicates Poor Prognosis in Hepatocellular Carcinoma.
    Liu J, Ni W, Qu L, Cui X, Lin Z, Liu Q, Zhou H, Ni R.
    Dig Dis Sci; 2016 Sep 10; 61(9):2554-67. PubMed ID: 27221498
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. SET7/9 promotes hepatocellular carcinoma progression through regulation of E2F1.
    Gu Y, Wang X, Liu H, Li G, Yu W, Ma Q.
    Oncol Rep; 2018 Oct 10; 40(4):1863-1874. PubMed ID: 30106440
    [Abstract] [Full Text] [Related]

  • 19. Long non-coding RNA CARLo-5 expression is associated with disease progression and predicts outcome in hepatocellular carcinoma patients.
    Wang F, Xie C, Zhao W, Deng Z, Yang H, Fang Q.
    Clin Exp Med; 2017 Feb 10; 17(1):33-43. PubMed ID: 26433964
    [Abstract] [Full Text] [Related]

  • 20. S100A14 promotes the growth and metastasis of hepatocellular carcinoma.
    Zhao FT, Jia ZS, Yang Q, Song L, Jiang XJ.
    Asian Pac J Cancer Prev; 2013 Feb 10; 14(6):3831-6. PubMed ID: 23886191
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.